Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Obesity has become more prevalent in most developed countries over the past few decades, and is increasingly recognized as a major risk factor for several common types of cancer. As the worldwide obesity epidemic has shown no signs of abating, better understanding of the mechanisms underlying obesity-associated cancer is urgently needed. Although several events were proposed to be involved in obesity-associated cancer, the exact molecular mechanisms that integrate these events have remained largely unclear. Here we show that senescence-associated secretory phenotype (SASP) has crucial roles in promoting obesity-associated hepatocellular carcinoma (HCC) development in mice. Dietary or genetic obesity induces alterations of gut microbiota, thereby increasing the levels of deoxycholic acid (DCA), a gut bacterial metabolite known to cause DNA damage. The enterohepatic circulation of DCA provokes SASP phenotype in hepatic stellate cells (HSCs), which in turn secretes various inflammatory and tumour-promoting factors in the liver, thus facilitating HCC development in mice after exposure to chemical carcinogen. Notably, blocking DCA production or reducing gut bacteria efficiently prevents HCC development in obese mice. Similar results were also observed in mice lacking an SASP inducer or depleted of senescent HSCs, indicating that the DCA-SASP axis in HSCs has key roles in obesity-associated HCC development. Moreover, signs of SASP were also observed in the HSCs in the area of HCC arising in patients with non-alcoholic steatohepatitis, indicating that a similar pathway may contribute to at least certain aspects of obesity-associated HCC development in humans as well. These findings provide valuable new insights into the development of obesity-associated cancer and open up new possibilities for its control.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Dose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752
Self-citationOverweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764
COLLINS, M. D., LAWSON, P. A., WILLEMS, A., CORDOBA, J. J., FERNANDEZ-GARAYZABAL, J., GARCIA, P., CAI, J., HIPPE, H., & FARROW, J. A. E. (1994) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-44-4-812 · Cited by 1,669
Cited by
Items 601–700 of 1,009
Research on Gut Microbiota-Derived Secondary Bile Acids in Cancer Progression
Yang, R., & Li, Q. (2022) · Integrative Cancer Therapies · doi:10.1177/15347354221114100 · Cited by 75
Obesity and Cancer: A Gut Microbial Connection
Ohtani, N., Yoshimoto, S., & Hara, E. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3501 · Cited by 71
Self-citationFerreira, D. M. S., Afonso, M. B., Rodrigues, P. M., Simão, A. L., Pereira, D. M., Borralho, P. M., Rodrigues, C. M. P., & Castro, R. E. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00420-13 · Cited by 70
Tibbs, T. N., Lopez, L. R., & Arthur, J. C. (2019) · Microbial Cell · doi:10.15698/mic2019.08.685 · Cited by 68
Publisher Correction: The gut–liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0031-8 · Cited by 70
Nguyen, P. T., Kanno, K., Phạm, Q. T., Kikuchi, Y. S., Kakimoto, M., Kobayashi, T., Otani, Y., Kishikawa, N., Miyauchi, M., Arihiro, K., et al. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03374-9 · Cited by 73
Elucidation of Gut Microbiota-Associated Lipids Using LC-MS/MS and 16S rRNA Sequence Analyses
Yasuda, S., Okahashi, N., Tsugawa, H., Ogata, Y., Ikeda, K., Suda, W., Arai, H., Hattori, M., & Arita, M. (2020) · iScience · doi:10.1016/j.isci.2020.101841 · Cited by 76
Self-citationDu, J., Zayed, A. A., Kigerl, K. A., Zane, K., Sullivan, M. B., & Popovich, P. G. (2021) · mSystems · doi:10.1128/msystems.01356-20 · Cited by 76
(2022) · doi:10.1016/j.hsr.2021.100010 · Cited by 69
Role of the microbiome in non-gastrointestinal cancers
Pevsner-Fischer, M., Tuganbaev, T., Meijer, M., Zhang, S.-H., Zeng, Z.-R., Chen, M.-H., & Elinav, E. (2016) · World Journal of Clinical Oncology · doi:10.5306/wjco.v7.i2.200 · Cited by 70
Li, F., Zhao, X., Tong, Q., Zhou, X., Chen, J., Xiong, W., Fang, J., Wang, W., & Shi, C. (2018) · Journal of Food Science · doi:10.1111/1750-3841.14128 · Cited by 69
Ponziani, F. R., Nicoletti, A., Gasbarrini, A., & Pompili, M. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919848184 · Cited by 69
Mechanistic understanding of β-cryptoxanthin and lycopene in cancer prevention in animal models
Lim, J. Y., & Wang, X. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158652 · Cited by 76
Formation of secondary allo-bile acids by novel enzymes from gut Firmicutes
Lee, J., Cowley, E. S., Wolf, P. G., Doden, H. L., Murai, T., Caicedo, K. Y. O., Ly, L. K., Sun, F.-R., Takei, H., Nittono, H., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2132903 · Cited by 77
Wei, X., Wang, F., Tan, P., Huang, H., Wang, Z., Xie, J., Wang, L., Liu, D., & Hu, Z. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107148 · Cited by 77
Telomeres, NAFLD and Chronic Liver Disease
Donati, B., & Valenti, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030383 · Cited by 69
The interplay between the microbiome and the adaptive immune response in cancer development
Russo, E., Taddei, A., Ringressi, M. N., Ricci, F., & Amedei, A. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16635082 · Cited by 74
Natural products as mediators of disease
Garg, N., Luzzatto‐Knaan, T., Melnik, A. V., Caraballo‐Rodríguez, A. M., Floros, D. J., Petras, D., Gregor, R., Dorrestein, P. C., & Phelan, V. V. (2017) · Natural Product Reports · doi:10.1039/c6np00063k · Cited by 76
Jain, U., Lai, C.-W., Xiong, S., Goodwin, V. M., Lu, Q., Muegge, B. D., Christophi, G. P., VanDussen, K. L., Cummings, B. P., Young, E., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.07.019 · Cited by 67
Cholecystectomy Damages Aging-Associated Intestinal Microbiota Construction
Wang, W., Wang, J., Li, J., Yan, P., Jin, Y., Zhang, R., Yue, W., Guo, Q., & Geng, J. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01402 · Cited by 76
Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH
Svegliati-Baroni, G., Patrício, B., Lioci, G., Macedo, M. P., & Gastaldelli, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165820 · Cited by 66
Microbiota and body weight control: Weight watchers within?
Boscaini, S., Leigh, S., Lavelle, A., García‐Cabrerizo, R., Lipuma, T., Clarke, G. A., Schellekens, H., & Cryan, J. F. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101427 · Cited by 74
The gut–liver axis: host microbiota interactions shape hepatocarcinogenesis
Silveira, M. A. D., Bilodeau, S., Greten, T. F., Wang, X. W., & Trinchieri, G. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.02.009 · Cited by 73
Zhang, R., Chen, H., & Liu, D. (2015) · Cell Systems · doi:10.1016/j.cels.2015.09.002 · Cited by 74
Oncobiosis and Microbial Metabolite Signaling in Pancreatic Adenocarcinoma
Kiss, B., Mikó, E., Sebő, É., Tóth, J., Ujlaki, G., Szabó, J., Uray, K., Bai, P., & Árkosy, P. (2020) · Cancers · doi:10.3390/cancers12051068 · Cited by 73
Airway Microbiota as a Modulator of Lung Cancer
Goto, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093044 · Cited by 70
First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure
Zwirner, S., Abu Rmilah, A. A., Klotz, S., Pfaffenroth, B., Kloevekorn, P., Moschopoulou, A. A., Schuette, S., Haag, M., Selig, R., Li, K., et al. (2024) · Cell · doi:10.1016/j.cell.2024.02.023 · Cited by 65
“We also quantified numbers of potentially protumorigenic senescent cells in NASH livers 33 but found no differences between HRX215-and vehicle-treated mice (Figures S4O and S4P).”
Chattopadhyay, I., Gundamaraju, R., Jha, N. K., Gupta, P. K., Dey, A., Mandal, C. C., & Ford, B. M. (2022) · Disease Markers · doi:10.1155/2022/2941248 · Cited by 68
Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinoma
Shen, R. D., Ke, L., Li, Q., Dang, X., Shen, S., Shen, J., Li, S., Liang, L., Peng, B., Kuang, M., et al. (2022) · Hepatology International · doi:10.1007/s12072-022-10299-7 · Cited by 71
Gut microbiota in regulatory T cell generation and function: mechanisms and health implications
Sharma, A., Sharma, G., & Im, S. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2516702 · Cited by 71
Murakami, M., Iwamoto, J., Honda, A., Tsuji, T., Tamamushi, M., Ueda, H., Monma, T., Konishi, N., Yara, S., Hirayama, T. T., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy022 · Cited by 68
Probiotics and their role in gastrointestinal cancers prevention and treatment; an overview.
Javanmard, A., Ashtari, S., Sabet, B., Davoodi, S. H., Rostami‐Nejad, M., Akbari, M. E., Niaz, A., & Mortazavian, A. M. (2018) · Gastroenterology and hepatology from bed to bench. · Cited by 97
Kompella, P., & Vásquez, K. M. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23048 · Cited by 72
Harnessing the Microbiome for Pancreatic Cancer Immunotherapy
Vitiello, G. A., Cohen, D. J., & Miller, G. (2019) · Trends in Cancer · doi:10.1016/j.trecan.2019.10.005 · Cited by 68
Probiotic species in the modulation of the anticancer immune response
Marinelli, L., Tenore, G. C., & Novellino, E. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.08.007 · Cited by 64
The immune landscape in nonalcoholic steatohepatitis
Narayanan, S., Surette, F. A., & Hahn, Y. S. (2016) · Immune Network · doi:10.4110/in.2016.16.3.147 · Cited by 64
“demonstrate that induction of the senescence phenotype in HSCs is associated with increased rates of hepatocellular carcinoma in mice exposed to a carcinogen that were fed a high-fat diet compared to normal diet fed mice (66).”
BackgroundNon-alcoholic Fatty Liver Disease and Liver Fibrosis during Aging
Li, Y., Adeniji, N., Fan, W., Kunimoto, K., & Torok, N. J. (2022) · Aging and Disease · doi:10.14336/ad.2022.0318 · Cited by 71
Yang, Y., Jn-Simon, N., He, Y., Sun, C., Zhang, P., Hu, W., Tian, T., Zeng, H., Basha, S., Huerta, A. S., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00811-7 · Cited by 65
Okushin, K., Tsutsumi, T., Enooku, K., Fujinaga, H., Kado, A., Shibahara, J., Fukayama, M., Moriya, K., Yotsuyanagi, H., & Koike, K. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1148-y · Cited by 68
Loftfield, E., Rothwell, J. A., Sinha, R., Keski‐Rahkonen, P., Robinot, N. R., Albanes, D., Weinstein, S. J., Derkach, A., Sampson, J. N., Scalbert, A., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz122 · Cited by 69
The Origin and Fate of Liver Myofibroblasts
Kim, H. Y., Sakane, S., Eguileor, A., Carvalho Gontijo Weber, R., Lee, W., Liu, X., Lam, K., Ishizuka, K., Rosenthal, S. B., Diggle, K., et al. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.09.008 · Cited by 63
Fujita, T., Soontrapa, K., Ito, Y., Iwaisako, K., Moniaga, C. S., Asagiri, M., Majima, M., & Narumiya, S. (2016) · Hepatology · doi:10.1002/hep.28112 · Cited by 63
Senescent stromal cells: roles in the tumor microenvironment
Gabai, Y., Assouline, B., & Ben‐Porath, I. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.09.002 · Cited by 68
Inflammation and gastrointestinal cancer: An overview
Marusawa, H., & Jenkins, B. J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.025 · Cited by 63
Su, B., Luo, T., Zhu, J., Fu, J., Zhao, X., Chen, L., Zhang, H., Ren, Y., Yu, L., Yang, X., et al. (2014) · Hepatology · doi:10.1002/hep.27551 · Cited by 67
Fndc5 loss‐of‐function attenuates exercise‐induced browning of white adipose tissue in mice
Xiong, Y., Wu, Z., Zhang, B., Wang, C., Mao, F., Liu, X., Hu, K., Sun, X., Jin, W., & Kuang, S. (2019) · The FASEB Journal · doi:10.1096/fj.201801754rr · Cited by 61
Virome and bacteriome: two sides of the same coin
Stern, J., Miller, G., Li, X., & Saxena, D. B. (2019) · Current Opinion in Virology · doi:10.1016/j.coviro.2019.05.007 · Cited by 67
Ma, H., Yang, L., Liang, Y., Liu, F., Hu, J., Zhang, R., Li, Y., Yuan, L., & Feng, F. (2024) · Gut Microbes · doi:10.1080/19490976.2023.2297846 · Cited by 69
Miyachi, T., Nagao, M., Shibata, C., Kitahara, Y., Tanaka, N., Watanabe, K., Tsuchiya, T., Motoi, F., Naitoh, T., & Unno, M. (2016) · Surgery · doi:10.1016/j.surg.2015.11.027 · Cited by 64
Gut Microbiota and Relevant Metabolites Analysis in Alcohol Dependent Mice
Wang, G., Liu, Q., Guo, L., Zeng, H., Ding, C., Zhang, W., Xu, D., Wang, X., Qiu, J., Dong, Q., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01874 · Cited by 61
Lee, H. A., Cho, J.-H., Afinanisa, Q., An, G.-H., Han, J., Kang, H., Choi, S. H., & Seong, H. (2020) · Nutrients · doi:10.3390/nu12113338 · Cited by 67
Kanwal, S., Aliya, S., & Xin, Y. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.558874 · Cited by 65
Sowah, S. A., Milanese, A., Schübel, R., Wirbel, J., Kartal, E., Johnson, T., Hirche, F., Grafetstätter, M., Nonnenmacher, T., Kirsten, R., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01030-0 · Cited by 67
Gender Differences in Adipocyte Metabolism and Liver Cancer Progression
Cheung, O. K.-W., & Cheng, A. S. L. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00168 · Cited by 67
The human gut virome databasePreprint
Gregory, A., Zablocki, O., Howell, A., Bolduc, B., & Sullivan, M. B. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/655910 · Cited by 66
Petrick, J. L., Florio, A. A., Koshiol, J. E., Pfeiffer, R. M., Yang, B., Yu, K. J., Chen, C., Yang, H., Lee, M., & McGlynn, K. A. (2020) · International Journal of Cancer · doi:10.1002/ijc.33051 · Cited by 70
Factors Affecting Gut Microbiome in Daily Diet
Su, Q., & Liu, Q. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.644138 · Cited by 68
Research Progress of Bile Acids in Cancer
Fu, J., Yu, M., Xu, W., & Yu, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.778258 · Cited by 67
Ferreira, D. M. S., Simão, A. L., Rodrigues, C. M. P., & Castro, R. E. (2014) · FEBS Journal · doi:10.1111/febs.12806 · Cited by 82
Senescence and cancer: An evolving inflammatory paradox
Ruhland, M. K., Coussens, L. M., & Stewart, S. A. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.10.001 · Cited by 60
Miura, K., Ishioka, M., Minami, S., Horie, Y., Ohshima, S., Goto, T., & Ohnishi, H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.709048 · Cited by 64
The gut microbiota: A new potential driving force in liver cirrhosis and hepatocellular carcinoma
Sanduzzi‐Zamparelli, M., Rocco, A., Compare, D., & Nardone, G. (2017) · United European Gastroenterology Journal · doi:10.1177/2050640617705576 · Cited by 68
Liver fibrosis: the 2017 state of art
Caviglia, G. P., Rosso, C., Fagoonee, S., Saracco, G. M., & Pellicano, R. (2017) · Panminerva Medica · doi:10.23736/s0031-0808.17.03359-6 · Cited by 68
Roles of microbiota in response to cancer immunotherapy
Inamura, K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.026 · Cited by 65
Bollrath, J., & Powrie, F. (2013) · Science · doi:10.1126/science.1242674 · Cited by 60
Hepatocellular Carcinoma: How the Gut Microbiota Contributes to Pathogenesis, Diagnosis, and Therapy
Luo, W., Guo, S., Zhou, Y., Zhao, J., Wang, M., Sang, L.-X., Chang, B., & Wang, B. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.873160 · Cited by 65
Heterogeneity, crosstalk, and targeting of cancer-associated fibroblasts in cholangiocarcinoma
Vilà, P. C., Ravichandra, A., Lizaso, A. A., Perugorria, M. J., & Affò, S. (2023) · Hepatology · doi:10.1097/hep.0000000000000206 · Cited by 72
Gut Microbiota: The Next-Gen Frontier in Preventive and Therapeutic Medicine?
Nagpal, R., Yadav, H., & Marotta, F. (2014) · Frontiers in Medicine · doi:10.3389/fmed.2014.00015 · Cited by 54
Gut microbiome as a novel cardiovascular therapeutic target
Singh, V., Yeoh, B. S., & Vijay–Kumar, M. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.01.002 · Cited by 62
Targeting the gut microbiota by dietary nutrients: A new avenue for human health
Li, D., Wang, P., Wang, P., Hu, X., & Chen, F. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1363708 · Cited by 62
Zheng, X., Liu, W., Xiang, J., Liu, P., Ke, M., Wang, B., Wu, R., & Lv, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.21525 · Cited by 65
Agosti, P., Sabbà, C., & Mazzocca, A. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.11.026 · Cited by 63
Devendran, S., Shrestha, R., Alves, J. M. P., Wolf, P. G., Ly, L., Hernandez, A. G., Méndez-García, C., Inboden, A., Wiley, J., Paul, O., et al. (2019) · Applied and Environmental Microbiology · doi:10.1128/aem.00052-19 · Cited by 61
Toda, G., Soeda, K., Okazaki, Y., Kobayashi, N., Masuda, Y., Arakawa, N., Suwanai, H., Masamoto, Y., Izumida, Y., Kamei, N., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.033 · Cited by 65
Self-citationBacterial SNPs in the human gut microbiome associate with host BMI
Zahavi, L., Lavon, A., Reicher, L., Shoer, S., Godneva, A., Leviatan, S., Rein, M., Weissbrod, O., Weinberger, A., & Segal, E. (2023) · Nature Medicine · doi:10.1038/s41591-023-02599-8 · Cited by 58
Filliol, A., & Schwabe, R. F. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1685539 · Cited by 58
Cellular Senescence in Liver Disease and Regeneration
Ferreira-Gonzalez, S., Rodrigo-Torres, D., Gadd, V. L., & Forbes, S. J. (2021) · Seminars in Liver Disease · doi:10.1055/s-0040-1722262 · Cited by 59
Studies of xenobiotic-induced gut microbiota dysbiosis: from correlation to mechanisms
Chi, L., Tu, P., Ru, H., & Lü, K. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1921912 · Cited by 61
Grgurević, I., Božin, T., Mikuš, M., Kukla, M., & O’Beirne, J. P. (2021) · Cancers · doi:10.3390/cancers13225844 · Cited by 61
Li, X., Zhao, W., Meng, X., Yu, L., Chen, Q., Hu, X., Zhao, Y., Xiong, L., Chen, X., Wang, X., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115333 · Cited by 61
Takahashi, Y., Dungubat, E., Kusano, H., & Fukusato, T. (2023) · Biomedicines · doi:10.3390/biomedicines11102761 · Cited by 65
A Crucial Role for CDC42 in Senescence-Associated Inflammation and Atherosclerosis
Ito, T. K., Yokoyama, M., Yoshida, Y., Nojima, A., Kassai, H., Oishi, K., Okada, S., Kinoshita, D., Kobayashi, Y., Fruttiger, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102186 · Cited by 57
Song, I. J., Yang, Y. M., Inokuchi‐Shimizu, S., Roh, Y. S., Yang, L., & Seki, E. (2017) · International Journal of Cancer · doi:10.1002/ijc.31029 · Cited by 64
Microbiota and Colorectal Cancer: From Gut to Bedside
Silva, M. G., Brunner, V., & Tschurtschenthaler, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.760280 · Cited by 66
Hisamoto, S., Shimoda, S., Harada, K., Iwasaka, S., Onohara, S., Chong, Y., Nakamura, M., Bekki, Y., Yoshizumi, T., Ikegami, T., et al. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.08.006 · Cited by 57
The therapeutic landscape of hepatocellular carcinoma
Gallage, S., Beccaria, M. G., Szydlowska, M., Rahbari, M., Mohr, R. U., Tacke, F., & Heikenwälder, M. F. (2021) · Med · doi:10.1016/j.medj.2021.03.002 · Cited by 64
Uchino, Y., Goto, Y., Konishi, Y., Tanabe, K., Toda, H., Wada, M., Kita, Y., Beppu, M., Mori, S., Hijioka, H., et al. (2021) · Cancers · doi:10.3390/cancers13133332 · Cited by 63
Self-citationIntertwined Relationship of Mitochondrial Metabolism, Gut Microbiome and Exercise Potential
Imdad, S., Lim, W., Kim, J., & Kang, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052679 · Cited by 75
Gut-specific telomerase expression counteracts systemic aging in telomerase-deficient zebrafish
Maï, M. E., Bird, M., Allouche, A., Targen, S., Şerifoğlu, N., Lopes-Bastos, B., Guigonis, J., Kang, D., Pourcher, T., Yue, J., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00401-5 · Cited by 68
New insights into the roles of peroxiredoxins in cancer
Liu, Y., Wang, P., Hu, W., & Chen, D. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114896 · Cited by 61
Liver regeneration in aged mice: new insights
Pibiri, M. (2018) · Aging · doi:10.18632/aging.101524 · Cited by 61
Xia, H., Liu, C., Li, C.-C., Fu, M., Takahashi, S., Hu, K.-Q., Aizawa, K., Suganuma, H., Wu, G. G., Zhao, L., et al. (2018) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-18-0188 · Cited by 61
Wang, J., Zheng, X., Qin, Z., Wei, L., Lu, Y., Qiu, P., Gao, Y., Zhang, X., Zhang, X., Li, Z., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006853 · Cited by 61
Tanaka, Y., & Takahashi, A. (2020) · The Journal of Biochemistry · doi:10.1093/jb/mvaa109 · Cited by 64
Gut microbiota: impacts on gastrointestinal cancer immunotherapy
Lau, H. C.-H., Sung, J. J. �., & Yu, J. Q. (2021) · Gut Microbes · doi:10.1080/19490976.2020.1869504 · Cited by 60
Reprogramming of Hepatic Metabolism and Microenvironment in Nonalcoholic Steatohepatitis
Rui, L., & Lin, J. D. (2022) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-062220-105200 · Cited by 56
Dysbiotic Gut Microbiota-Derived Metabolites and Their Role in Non-Communicable Diseases
Tan, J., Taitz, J., Nanan, R. K. H., Grau, G. E., & Macia, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015256 · Cited by 64
Li, C., Cai, C., Wang, C., Chen, X., Zhang, B., & Huang, Z. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0857 · Cited by 63
Nakagawa, H. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i17.2110 · Cited by 63
Zhou, L., Qi, L., Jiang, L., Zhou, P., Ma, J., Xu, X., & Li, P. (2014) · The AAPS Journal · doi:10.1208/s12248-013-9558-3 · Cited by 60
Metadata
- Authors
- Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., Honda, K., Ishikawa, Y., Hara, E., & Ohtani, N.
- Affiliations
- Japanese Foundation For Cancer Research (JP)
- Tokyo University of Science (JP)
- Japan Science and Technology Agency (JP)
- Tokushima University (JP)
- The University of Tokyo (JP)
- Azabu University (JP)
- Corresponding author
- Hara, Eiji
- ORCID
- Venue
- Nature
- Published
- 2013-06-26
- Volume
- 499
- Issue
- 7456
- Pages
- 97-101
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2132406938
- Cited by
- 2,219
- References
- 40
- Citations by year
- 2026: 131 · 2025: 164 · 2024: 175 · 2023: 196 · 2022: 208 · 2021: 224 · 2020: 198 · 2019: 175 · 2018: 172 · 2017: 142 · 2016: 130 · 2015: 125 · 2014: 125 · 2013: 47
- FWCI
- 63.80
- Type
- journal article
- Language
- en
- Update notices
- erratum (2014-01-29)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Takeda Science Foundation
- Uehara Memorial Foundation
- Japan Society for the Promotion of Science (23300343, 221S0001, 24650625, 23300352, 25293080)
- Japan Science and Technology Agency
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- obesity, hepatocellular carcinoma, senescence-associated secretory phenotype, deoxycholic acid, gut microbiota, hepatic stellate cells, high-fat diet, bile acid metabolism, DNA damage, carcinogenesis, antibiotic intervention, chemical carcinogens, inflammation, obesity-related cancer, therapeutic target, mouse model
- MeSH terms
- Animals, Anti-Bacterial Agents, Bacteria, Bile Acids and Salts, Cells, Cultured, Deoxycholic Acid, Dietary Fats, Disease Models, Animal, DNA Damage, Fatty Liver, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Mice, Inbred C57BL, Obesity, Phenotype, Risk Factors, Cytokines, Cellular Senescence, Gastrointestinal Tract, Mice, Interleukin-1beta, Hepatic Stellate Cells, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.